CAMLINFINE - Camlin Fine Sciences

Camlin Fine Sciences

CAMLINFINE · Chemicals > Chemicals · Chairman: Ashish Dandekar · MD: Ashish Dandekar · Listing date: Jan. 20, 2015 · Employees: 430 · Mumbai · http://www.camlinfs.com

Stock Price vs Company Growth

0.3%

0.1%

15.1%

28.6%

75.2%

74.9%

33.6%

10y

7.5%

all

7.3%

🤔 How to analyze this graph?

Last Traded Price

₹ 172 0.3%

113

181

Company Overview

Sales

1,654 Cr

Growth: -0.5%

Profit after Tax

-215 Cr

Growth: -3.4%

Small Cap

3,231 Cr

P/S: 2.0x

Industry P/S: 1.9x

Fundamentals

Sales (Cr)	₹ 1,654
Growth	-0.5%
EBITDA	5.9%
P/S	2.0x
Dividend	0.0%
P/E	-13.5x
Book Value	₹ 38.7
PEG Ratio	27.8x
ROE	-27.3%
P/B	4.5x

Shareholding Pattern

Institutions

Icici Prudential Midcap Fund

8.62 %

Sbi Flexicap Fund

7.93 %

Infinity Direct Holding

4.82 %

Nirmal Vinod Momaya

2.82 %

Kuwait Investment Authority Fund 225

1.99 %

Promoters

Ashish Subhash Dandekar

11.02 %

Camart Industries Ltd

4.17 %

Vibha Agencies Pvt Ltd

2.04 %

Anagha Subhash Dandekar

1.19 %

Cafco Consultants Limited

1.17 %

Others

Increase Decrease No change

Company Profile Detailed

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956.

Belongs to (8 Indices) view more

Investors (93)

infinity...

visa.cap...

sbi.magn...

Followers (7)

sudheer....

ratnesh2

indrajee...